213Bi-C595

N/A

Report date: 2025/11/12 17:54:35

Base Information

Drug Name213Bi-C595
Drug Alias Name213Bi-NCRC48213Bi-C595(213)Bi-C595
ClassificationRadiation-emitting products > Nuclides > Bismuth > 213BiRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4
Mechanisms of ActionAnti-MUC1
TargetsMucin-1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A